CoChat

Arterial Hypertension, Atrial Fibrillation, and Hyperaldosteronism: The Triple Trouble

Open access
Seccia, Teresa M., Caroccia, Brasilina, Adler, Gail K., Maiolino, Giuseppe, Cesari, Maurizio, Rossi, Gian Paolo · 2017 · Hypertension
Cited by 66

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

Atrial fibrillation (AF) involves 1% to 2% of the adult general population, a rate that increases to 15% in those 80 years and above.1 Because of the aging of the general population, this epidemic of AF is expected to increase over the next decades2–4 and to impose an increasing burden on the healthcare system because of the need for life-long care and pharmacological treatment. Identification of the mechanisms underlying AF represents an unmet need and a first step toward developing more effective preventive measures. Arterial hypertension (HT) is tightly associated with AF, as originally reported in the Framingham Heart Study5 and thereafter confirmed by several studies.6–13 HT is a major predictor of AF, and 50% to 90% of AF patients have HT. Accumulating evidences point to a role for the renin–angiotensin–aldosterone system (RAAS) in the pathophysiology of cardiac inflammation, fibrosis, and hypertrophy.14–17 Aldosterone not only exerts well-known pressor effects, but also promotes inflammation, myocardial necrosis, cardiac collagen deposition, fibrosis, and left ventricular hypertrophy (LVH).18,19 Accordingly, there is renewed interest in aldosterone as one of the major culprits leading to chamber remodeling and ultimately creating the stage for AF in hypertensive patients.15,17,20–25 The evidence supporting a role for aldosterone in AF was, however, derived from observational studies performed in patients with heart diseases that are known to cause AF. This leaves open the question of whether aldosterone triggers AF per se or only in the presence of structural heart disease. In recent years, 3 reviews examined the relation between aldosterone and AF: one focused on the antiarrhythmic potential of mineralocorticoid receptor (MR) antagonists in AF patients;26 another on the role of the MR in arrhythmias;27 and the last …

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/hypertensionaha.116.08956

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Cited by

See all 66

Metadata

Authors
Seccia, T. M., Caroccia, B., Adler, G. K., Maiolino, G., Cesari, M., & Rossi, G. P.
Venue
Hypertension
Published
2017-04
Volume
69
Issue
4
Pages
545-550
ISSN
  • 0194-911X (ISSN-L)
  • 1524-4563
OpenAlex
W2592956313
Cited by
66
References
9
FWCI
6.68
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Arterial Hypertension, Atrial Fibrillation, and Hyperaldosteronism: The Triple Trouble. https://app.cochat.ai/papers/10.1161/hypertensionaha.116.08956
The paper
Seccia, T. M., Caroccia, B., Adler, G. K., Maiolino, G., Cesari, M., & Rossi, G. P. (2017). Arterial Hypertension, Atrial Fibrillation, and Hyperaldosteronism: The Triple Trouble. Hypertension. https://doi.org/10.1161/hypertensionaha.116.08956

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.